Hólyagrák: vizsgálatok itt: Kína
167 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaMultimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 36
- Run by
- Peking University First Hospital
See details and how to joinNCT07504939 - 2. fázisTaking peopleStudy of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
- Where
- Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Jinan, Nanjing, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan
- Életkor
- 18 év and over
- People
- 16
- Run by
- Lepu Biopharma Co., Ltd.
See details and how to joinNCT07283835 - 1. fázisCsak meghívásosPropranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 12
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07353294 - No phaseTaking peopleDetecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 250
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07514897 - 2. fázisTaking peopleTrastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy
- Where
- Shenyang
- Életkor
- 18 év to 85 év
- People
- 20
- Run by
- Xiujuan Qu
See details and how to joinNCT07506057 - 2. fázisNot yet taking people in KínaProbiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 146
- Run by
- chenxu
See details and how to joinNCT07474064 - No phaseCsak meghívásosArtificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 4000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07454941 - No phaseTaking peopleNectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT05321316 - No phaseTaking peopleThe Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 60
- Run by
- Tianjin Medical University Second Hospital
See details and how to joinNCT07130578 - No phaseTaking peopleUsing Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 300
- Run by
- Tianjin Medical University Second Hospital
See details and how to joinNCT07441499 - No phaseTaking peopleMultiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
- Where
- Lanzhou
- Életkor
- 18 év and over
- People
- 400
- Run by
- Zhilong Dong
See details and how to joinNCT07424560 - 1/2. fázisTaking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - 2. fázisNot yet taking people in KínaNECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- Peking University Third Hospital
See details and how to joinNCT07412171 - No phaseTaking peopleEvaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 266
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07379255 - No phaseTaking peopleEvaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 224
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07379268 - No phaseTaking peopleEvaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 254
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07379281 - 1. fázisTaking peopleSafety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 29
- Run by
- Tongji Hospital
See details and how to joinNCT07359235 - No phaseTaking peopleAdaptive Radiotherapy for Genitourinary Cancers
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07324798 - No phaseTaking peopleEstablishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 3000
- Run by
- Peking University First Hospital
See details and how to joinNCT07319923 - 2. fázisTaking people9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 90
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT07314723 - No phaseTaking peopleAdjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 178
- Run by
- Peking University First Hospital
See details and how to joinNCT06120374 - 2. fázisTaking peopleNeoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
- Where
- Fuzhou, Hangzhou, Jinan, Nanchang, Putian, Quanzhou, Sanming, Shanghai, Wenzhou, Xiamen, Zhangzhou
- Életkor
- 18 év to 85 év
- People
- 25
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07296705 - 2. fázisTaking peopleA Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Peking University First Hospital
See details and how to joinNCT06210490 - No phaseTaking peopleCirculating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 84
- Run by
- RenJi Hospital
See details and how to joinNCT05595408 - 2. fázisTaking peopleCombination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
- Where
- Shanghai
- Életkor
- 18 év to 90 év
- People
- 20
- Run by
- RenJi Hospital
See details and how to joinNCT05912816